Search tool

Displaying 1 - 10 of 18

Document library

Regulation (EU) 1258/2013

This regulation amends Regulation (EC) No 273/2004 of the European Parliament and of the Council of 11 February 2004 on drug precursors which establishes harmonised measures for the control and monitoring of...

Document library

Regulation (EU) 1259/2013

Document library

Getting up to speed with the public health and regulatory challenges posed by new psychoactive substances in the information age

Some new drugs appear to have a limited potential for diffusion, but they may still cause serious harm. Stakeholders, including policy makers, practitioners and researchers, will increasingly need access to timely evidence-based...

EMCDDA welcomes European Commission call for stronger EU action on new drugs

The EU drugs agency (EMCDDA) welcomes the European Commission's proposal today to strengthen the EU’s response to new psychoactive substances (‘new drugs’)(1). The proposal follows an unprecedented rise in the number of...

Experts to examine latest scientific research in the field of new drugs

Novel (or new) psychoactive substances (NPS) are an ever-increasing group of synthetic, semi-synthetic or natural compounds, often advertised and sold as ‘legal’ alternatives to illicit drugs. Often misrepresented as ‘safe’ for recreational...

Document library

The European drug landscape in 2013 - highlights from the EMCDDA's European drug report

May 2013 saw the publication of the first European Drug Report (EDR), the European Monitoring Centre for Drugs and Drug Addiction’s (EMCDDA) comprehensive and multi-dimensional package providing information on European drug trends...

Document library

Computer-aided (in silico) approaches in the mode-of-action analysis and safety assessment of ostarine and 4-methylamphetamine

We show that in silico target prediction appears to have potential in assessing new psychoactive compounds where experimental data are scarce.

Third international multi-disciplinary forum on new drugs

27.06.2013 to 28.06.2013

Leading European and international experts will meet in Lisbon from 27–28 June for the Third international multidisciplinary forum on new drugs, jointly organised by the EMCDDA and Europol. The event follows on...

Lisbon, Portugal

G8 statement of intent on collecting and sharing of data on new drugs

New psychoactive substances (NPS) have changed the nature of the global drugs market. Substances that are not under international control, but mimic the effects of controlled substances, are now widely available. NPS...

Over 100 specialists from across the globe to review international developments in new drugs field

Leading European and international specialists will meet in Lisbon from 27–28 June to take stock of the global new drugs phenomenon. The Third international multidisciplinary forum on new drugs, organised by the...